HPV Vaccine Prevented 448 Cervical Cancers in Young English Women

England's HPV vaccination programme averted an estimated 448 cervical cancer cases in women under 30 between 2016 and 2019, according to an NHS audit. This is the first measurable population-level evidence of the vaccine's effectiveness in clinical practice. The finding arrives as newer evidence shows screening intervals can be safely extended for vaccinated women—though England's current coverage rates of 76.7% for females and 71.2% for males still fall short of the 90% threshold needed for disease elimination.